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Abstract
Background: There is increasing evidence that the substantial global burden of disease for tuberculosis unfolds in
concert with dimensions of common mental disorders. Person-centred care holds much promise to ameliorate
these comorbidities in low-to-middle income countries (LMICs) and emerging economies. Towards this end, this
paper aims to review 1) the nature and extent of tuberculosis and common mental disorder comorbidity and 2)
person-centred tuberculosis care in low-to-middle income countries and emerging economies.
Main text: A scoping review of 100 articles was conducted of English-language studies published from 2000 to 2019 in
peer-reviewed and grey literature, using established guidelines, for each of the study objectives. Four broad tuberculosis/
mental disorder comorbidities were described in the literature, namely alcohol use and tuberculosis, depression and
tuberculosis, anxiety and tuberculosis, and general mental health and tuberculosis. Rates of comorbidity varied widely
across countries for depression, anxiety, alcohol use and general mental health. Alcohol use and tuberculosis were
significantly related, especially in the context of poverty. The initial tuberculosis diagnostic episode had substantial socio-
psychological effects on service users. While men tended to report higher rates of alcohol use and treatment default,
women in general had worse mental health outcomes. Older age and a history of mental illness were also associated with
pronounced tuberculosis and mental disorder comorbidity. Person-centred tuberculosis care interventions were almost
absent, with only one study from Nepal identified.
Conclusions: There is an emerging body of evidence describing the nature and extent of tuberculosis and mental
disorders comorbidity in low-to-middle income countries. Despite the potential of person-centred interventions,
evidence is limited. This review highlights a pronounced need to address psychosocial comorbidities with tuberculosis
in LMICs, where models of person-centred tuberculosis care in routine care platforms may yield promising outcomes.
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Background
Tuberculosis (TB) remains a significant cause of the global
disease burden, especially among disadvantaged popula-
tions. In 2018, approximately 10 million people developed
clinical disease, of whom about half a million new cases
were rifampicin resistant. 1.3 million people co-infected
with HIV and 300 000 without HIV died [1]. The inextric-
able relationship between TB and mental disorders is well
known although less well-researched. Mental illnesses such
as anxiety, mood and addiction disorders may have a high
comorbidity rate among people suffering from TB [2–4],
possibly with multidirectional relationships. Mental and
substance use disorders increases risk factors to TB disease
progression, such as tobacco smoking and poor nutrition,
often compounded by additional conditions such as dia-
betes and HIV infection [2].
Common mental disorders (CMD), including substance
abuse, are key mechanisms in medication adherence behav-
iour [5]. Alcohol use raises the risk of transmission due to
patterns of social behaviour (i.e. increased exposure in con-
gregate settings like bars), impairing the immune system
and, raising the odds for infection [6]. Stigma in relation to
mental illness and TB creates significant barriers to the pre-
vention and cure of TB in many communities. This in-
cludes the composite of stigmatising effects of comorbidity
between TB, mental disorders and stigmatised diseases
such as HIV [7]. In short, both proximal and distal associa-
tions between TB and CMDs unfold within multiple bio-
logical and psychosocial causal pathways, even though
these mechanisms remain under-researched [3]. The bulk
of TB diseases is experience in low-to-middle income coun-
tries and emerging economies (BRICS: Brazil, Russia, India,
China and South Africa) [1]. However, there limited
research that suggests that treatment of psychological as-
pects of TB may lead to improved clinical outcomes.
In India, psychotherapy during treatment resulted in
improved adherence, treatment and cure outcomes [8];
group-based psychological support for patients with mul-
tidrug resistant tuberculosis (MDR-TB) in Peru improved
treatment outcomes [9]; and in Ethiopia, ‘TB clubs’ both
reduced stigma and improved treatment outcomes among
patients [10], and an educational and psychological inter-
vention improved treatment adherence [11].
The need to comprehend and address the TB-mental ill-
ness nexus has become more pronounced in low-to-middle
income countries (LMICs) against the drive towards more
holistic, intersectoral, person-centred health systems [12],
backed by the Sustainable Development Goals (SDGs) [13].
Following these directives, there is a pressing need to de-
velop and refine evidence-based interventions towards im-
proving person-centred care in addressing TB and common
mental disorder comorbidity. There is however a distinct
gap in current literature that systematically describes and ex-
amines the LMIC epidemiology of TB and mental disorders,
as well as best practices in addressing this complex comor-
bid condition in LMIC health systems. The present study is
located within a larger research consortium brought
together to address key challenges plaguing health systems
in sub-Sahara African countries (ASSET: heAlth System
StrEngThening in sub-Saharan Africa), funded by the Na-
tional Institute for Health Research (NIHR) in the United
Kingdom [14]. One of the research packages of this
programme focuses on developing person-centred care
(PCC), especially in the contexts of comorbidities between
TB and mental disorders.
PCC is an important ideal for TB treatment and care, a
disease with a long and damaging social history, the diagno-
sis of which causes profound stigma, marginalisation and
harm to the sense of self and personhood [15] – especially
in conjunction with mental disorders [3]. Person-centred
interventions have yielded significant benefits in improving
psychological well-being and positive effects on behavioural
symptoms and treatment adherence in dementia care [16–
18], with promising effects on a range of outcomes in other
kinds of clinical care [19, 20]. Nonetheless, the effectiveness
of person-centred approaches to TB care is yet to be sys-
tematically and robustly investigated, especially in LMICs.
It remains to be determined which principles and dimen-
sions of PCC could improve TB care outcomes, but for the
purposes of this review we focus on the concepts of person
narrative, care collaboration and continuity. Person narra-
tive focuses on decision-making based on rich information
about the subjective experiences and attitudes of the
patient, beyond biomedical symptoms; care collaboration
includes the degree of collaboration between caregiver and
patient during assessment, decision-making and care plan-
ning; and continuity refers to care as an on-going process
that, in conjunction with person narrative, can be adapted,
revised and reinterpreted [21].
We report a scoping review to inform the development
of a person-centred package of TB care in primary
healthcare (PHC) clinics in rural South Africa [14]. The
objectives of the scoping review are two-fold:
1. To describe the nature and extent of TB and common
mental (anxiety, mood) and substance use disorder
comorbidity in LMICs and the BRICS region.
2. To explore person-centred care approaches to TB
and mental and substance use disorder comorbidi-
ties in LMICs and the BRICS region.
Methods
Key definitions
There is no universally accepted, unified definition for
person-centred care (PCC) [22, 23]. The term is often used
interchangeably with related concepts such as “patient partici-
pation”, “patient empowerment” and “patient-centredness”
[22–26]. Despite conceptual congruence in terms of
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dimensions such as a holistic perspective on the patient’s ill-
ness experience, an enabling collaborative therapeutic alliance
between care giver and receiver [23, 24], and values such as
empathy and respect [25], PCC has important distinctions.
Approaches such as patient-centred care focuses on interac-
tions in terms of visits and contact episodes; disease manage-
ment; comorbidity as multiple diseases; body systems as
distinct; professionally defined coding; and the evolution of
disease. PCC, on the other hand, highlights interrelationships
over time; illness episodes in a life-course perspective; the in-
terrelated nature of body systems, diseases and morbidity;
coding systems that allow for service user concerns; and con-
siders both the evaluation of disease and people’s illness ex-
perience [27]. Person-centredness in care aims to understand
1) a person’s subjective experiences and interpretations of ill-
ness by considering psychosocial dimensions alongside bio-
medical symptomology, 2) adhere to the centrality of shared
decision-making and parity, and 3) the primacy of relation-
ships in care and treatment [28].
Study design and literature search strategies
A scoping review was conducted in line with criteria out-
lined by Arksey and O’Malley [29] and the Johanna Briggs
Institute [30]. The following steps were followed: 1) Clear
research objectives were developed and refined among re-
search team members, following a brief review of key lit-
erature; 2) Relevant studies were identified by members of
the research team; 3) Key studies were selected by mem-
bers of the research team; 4) Data extracted from selected
studies were charted; 5) Findings were collated, thematic-
ally analysed and reported using Preferred Reporting
Items for Systematic reviews and Meta-Analyses Exten-
sion for Scoping Reviews (PRISMA-ScR) [31].
Study selection and data abstraction
The search included English-language studies published
within the period 2000–2019 in peer-reviewed and grey lit-
erature. From May to October 2018, two researchers (AvR
and AD) independently searched PubMed Health Source
(Academic/Nursing Edition); MEDLINE; PsychARTICLES;
Psychinfo; the World Health Organization website; Google
and Google Scholar. Different iterations of search terms
where used in combination for each research objective
(Table 1). For example, for Objective 1, the terms tubercu-
losis OR TB AND mental disorders OR mental illness OR
mental health were entered, with the limiters Abstract, Pub-
lication date from 2000/01/01 to 2018/12/31, English, Adult:
19+ years, Adult: 19–44 years. For a list of all search terms
Table 1 Complete search strategy by objective and database
Database Date Search terms applied Limiters applied
Objective 1: Comorbidity between
tuberculosis and mental disorders
PubMed 16/05/2018 ((((“tuberculosis”) OR TB) AND “mental disorders”)
OR mental illness) OR mental health
Abstract, Publication date from 2000/01/01 to
2018/12/31, English, Adult: 19+ years, Adult:
19–44 years.
Ebscohost: Health Source
(Academic/Nursing Edition);
Medline; PsychARTICLES;
Psychinfo
05/07/2018 TI (tuberculosis or tb) AND AB (mental health or
mental illness or mental disorder or psychiatric illness)
Abstract, Publication date from 2000/01/01 to
2018/12/31, English, Adult: 19+ years, Adult:
19–44 years.
Objective 2: Person-centred
tuberculosis care
PubMed 23/07/2018 (“patient centred care”) OR “person centred care”)
AND “tuberculosis”
Abstract, Publication date from 2000/01/01 to
2018/12/31, English, Adult: 19+ years, Adult:
19–44 years.
PubMed 23/07/2018 (tuberculosis or tb) AND AB (mental health or mental
illness or mental disorder or psychiatric illness) AND
AB (person centred care or patient centred care or
holistic care or relationship centred care or
individualised care)
Abstract, Publication date from 2000/01/01 to
2018/12/31, English, Adult: 19+ years, Adult:
19–44 years.
Ebscohost: Health Source
(Academic/Nursing Edition);
Medline; PsychARTICLES;
Psychinfo
23/07/2018 (tuberculosis or tb) AND AB (person centred care or
patient centred care or holistic care or relationship
centred care or individualised care)
Abstract, Publication date from 2000/01/01 to
2018/12/31, English, Adult: 19+ years, Adult:
19–44 years.
PubMed 14/12/2018 (((“persons”[MeSH Terms] OR “persons”[All Fields] OR
“person”[All Fields]) AND centred [All Fields] AND care
[All Fields]) OR ((“persons”[MeSH Terms] OR “persons”
[All Fields] OR “people”[All Fields]) AND centred [All
Fields] AND care [All Fields])) AND (“tuberculosis”[MeSH
Terms] OR “tuberculosis”[All Fields]) AND (hasabstract
[text] AND (“2000/01/01”[PDAT]: “2018/12/31”[PDAT])
AND (“adult”[MeSH Terms] OR “adult”[MeSH Terms:noexp]))
Abstract, Publication date from 2000/01/01 to
2018/12/31, English, Adult: 19+ years, Adult:
19–44 years.
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and limiters employed see Table 1. The reference lists of
key publications with high relevance were also searched,
and PubMed’s similarity function was used to find articles
excluded by the search terms. Two researchers independ-
ently reviewed the titles of search results for appropriate-
ness, followed by a review of article abstracts. Where
differences between the two researchers were noted, a third
researcher was consulted. The inclusion criteria were: evi-
dence from LMICs and BRICS countries, published since
year 2000 and, and focused on both TB and mental disor-
ders. The citations of these initial searches were imported
into Endnote X9 (bibliography management software) [32]
and exported to systematic review application Rayyan [33]
for management and review. These systematic steps are pre-
sented in PRISMA flowchart format [34]. Once a final list of
relevant articles was identified for each research objective,
electronic versions were imported into NVivo version 12.1
(a qualitative data analysis software aiding thematic analysis
of literature or qualitative research) [35] for management. A
thematic analysis of the final group of articles were con-
ducted in order to generate a narrative account of existing
literature relevant to the two research objectives [29].
Results
For Objective 1, a total of 868 articles were initially iden-
tified (see Fig. 1). After screening the titles and abstracts
for appropriateness, 737 articles were excluded because:
The scope of the article did not include TB and mental
disorders; did not focus on LMICs or BRICS; fell outside
the 2000–2019 time limit; did not focus on adults. In the
next phase, 131 articles were screened in full, using the
same limiters, resulting in the exclusion of 31 articles.
Thus 100 articles were included in the thematic analysis.
In terms of Objective 2, an initial number of 357 arti-
cles were identified (Fig. 2). After title and abstract
screening, 157 articles were excluded because: The scope
of the article did not include person-centred/patient-
centred/community-centred approaches to TB care; did
not focus on LMICs or BRICS; fell outside the 2000–
2019 time limit; did not focus on adults. Thirty-two arti-
cles were excluded following full-text review, with only
two papers included in the thematic analysis.
Several themes emerged during analysis. Four broad
TB/mental disorder comorbidities were described in the
literature, namely alcohol use and TB, depression and
TB, anxiety and TB, and general mental health and TB
(meaning that no specific disorders or psychiatric symp-
toms were identified). Studies generally did not include a
clinical psychiatric diagnosis according to international
guidelines, instead depending on measures such as qual-
ity of life as a proxy for mental wellness, or measure-
ments of mental distress. Therefore, these studies did
Fig. 1 Search results for papers describing the nature and extent of tuberculosis and mental (anxiety, mood and substance use) disorder
comorbidity in LMICs and BRICS (2000–2019)
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not strictly focus on TB and mental health comorbidities,
but rather on the nexus between TB disease and psycho-
logical symptomology. For the different comorbidities,
sub-themes that emerged included Comorbid TB and
mental illness symptom rates; Associations between TB
and mental illness symptoms; TB disease progression and
mental illness symptoms; and Factors influencing relation-
ships between TB and mental illness symptoms.
Comorbid TB and mental illness symptom rates
Rates of mental illness symptoms among TB patients
were collated according to depressive symptoms, anxiety,
alcohol use, and general mental health (Table 2). Studies
that did not specify depression, anxiety or alcohol use –
for instance psychological distress – were included
under general mental health. Prevalence of depressive
symptoms varied dramatically from 9% in Zambia [59]
to 84% in India [46]. Likewise anxiety-related symptoms
from 2% in India [46] to 47% in Pakistan [43] – gender
differences were not widely explored. Alcohol use was
measured in a variety of ways: questions on alcohol use
habits, references to alcoholism, and use of Alcohol Use
Disorders Identification Test (AUDIT). Indications of
harmful alcohol use ranged from 4% in Kazakhstan to
67% in Estonia [81]. Men were far more likely to engage
in harmful alcohol use.
Associations between TB and mental illness
Several studies explored associations between mental ill-
ness symptoms and TB disease. One metanalysis of the
period between 2000 and 2014 suggested that as alcohol
consumption increases, so does the risk of contracting TB
and alcohol-attributable TB mortality. The study esti-
mated that alcohol consumption was responsible for 17%
of TB incidence and 15% of TB mortality [98]. The likeli-
hood of TB treatment non-adherence is increased by
heavy alcohol use [41, 65, 70, 97]. Alcohol use intersects
with TB biologically (through immunosuppression) and
socially (increased exposure in closed, poorly ventilated
spaces such as taverns and bars) [94, 98]. Further, both al-
cohol use and TB are “diseases of poverty”, compounding
risk in poorer people [94, 99]. TB patients who use alcohol
are perceived to be “difficult” by healthcare workers,
poorly cooperative and challenging to manage [100]. Pa-
tients with TB who also use alcohol were more likely to
exhibit risky behaviours and are at a higher risk of con-
tracting HIV [69]. The combination of HIV co-infection
and heavy alcohol use prolongs the duration of cough
prior to presentation at a health facility [41].
In terms of the influence of the disease on emotional
well-being, several studies highlighted impact of a TB diag-
nosis on mental health. The period following diagnosis is
significantly associated with subsyndromal depression, and
Fig. 2 Search results for papers describing person-centred care approaches to tuberculosis and mental disorder comorbidities in LMICs and
BRICS (2000–2019)
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brief depressive episodes [4]. This emotional toll may be
mediated more through role limitation and increased men-
tal distress than physical symptoms [39]. Social stigma and
isolation may entrench such feelings [54, 101–104]. A TB
diagnosis is associated with a loss of self-esteem, fears of re-
jection and infecting loved ones [105]. Psychological dis-
tress appears to be exacerbated by heavy alcohol use,
female gender, previous episodes of TB, and increased mor-
bidity [41]. A Peruvian study reported that people suffering
both from TB and HIV expressed a need for support from
a psychologist with shortages of mental health professionals
impacting negatively on patients’ mental health [103].
These effects are amplified in MDR-TB. A study evaluating
the quality of life associated with MDR-TB found that pa-
tients suffered from severe physiological, financial and psy-
chological challenges, which persisted beyond treatment
completion, and resulted in survival adaptation, poor gen-
eral health, loss of freedom and agency, and a lack of social
participation [102].
TB disease progression and mental illness symptoms
Diagnosis phase and mental illness
The exact causal pathways between TB disease and mental
illness are unclear. Few studies have systematically ex-
plored longitudinal dimensions between mental illness
symptoms and the progression of TB disease, where the
diagnosis and treatment initiation stages pose substantial
risk for mental illnesses. At diagnosis the following are
common: anxiety related symptoms [47, 104], related to
fears of death, serious illness, and limited knowledge of TB
disease [106, 107], depressive feelings, feelings of worry
and embarrassment as well as shame [105]. A TB diagnosis
can lead to shock, anxiety and shame, with high levels of
psychological distress [55, 103, 107]. At this phase, psycho-
logical issues are more severe with family, community and
social issues becoming more salient during and after the
treatment phase [108]. One study found TB patients with
elevated levels of psychological distress were more likely to
die during treatment than those with lower levels [41].
Additionally, the risk of mental illness is greater in MDR-
TB. MDR-TB patients have a high likelihood of having de-
pression, throughout the illness experience [39]. One study
suggested that mental, social and physical challenges posed
by MDR-TB were related to deteriorating health-related
quality of life scores as the disease progresses [39]. A review
of studies on MDR-TB reported that MDR-TB patients
face a range of psychological issues, including emotions of
hopelessness and fear, accentuated by being conscious of
the finality of MDR-TB treatment as a last option [108].
Treatment initiation phase and mental illness
TB patients with depressive symptoms are more likely to
experience negative TB outcomes than those without
such symptoms [38]. Several studies involving mental
health measures suggest TB treatment adherence re-
duces mental illness symptoms. Mental health domains
of health-related quality of life assessments have shown
to significantly improve following initial phases of TB
treatment [39, 101, 109–111]. Risk of developing depres-
sion has shown to decrease over the course of TB treat-
ment [112] and adherence shown to improve depressive
symptoms of patients suffering from MDR-TB [51].
Initial emotional shock and increased mental health
toll, along with lack of health education and emotional
support during diagnosis and treatment initiation, ele-
vate this period as critical for emotional and educational
intervention [41, 103, 108]. In many countries screening
and treating psychological challenges among persons di-
agnosed with TB is limited. This is especially true for al-
cohol use disorders and its associated impact on
prognosis during treatment; people in TB retreatment
programmes are more likely to show risky alcohol use
patterns [94]. Further, national TB programmes in coun-
tries such as South Africa and India primarily frame TB
treatment in biomedical terms, focusing on clinical out-
comes such as sputum conversion. However, patients
may not regard their treatment as successful due to the
impact on the disease and treatment episode – this in-
cludes a breakdown in social relationship ties, job loss,
social exclusion and a loss of identity [102, 113].
Factors influencing relationships between TB and mental
illness symptoms
Factors related to gender
The literature identified several important factors that influ-
ence relationships between TB and different dimensions of
mental illness. Gender is an especially pronounced factor:
during diagnostic and treatment phases of TB treatment,
women have consistently shown to have significantly poorer
mental health outcomes, including general mental health
[39], anxiety [47], depression [4, 49, 52, 59, 84], psycho-
logical distress [40, 41, 83, 114], suicidality [59] and mental
health-related quality of life. However in one exception, men
scored higher than women in an outpatient hospital setting
in Uttar Pradesh, India [46]. Regarding alcohol use, men are
more likely to consume alcohol at harmful levels prior to
and during a TB episode [55, 90, 94, 104, 115]. Men also
seem less likely to adhere to treatment regimens [116].
Women may cope differently with TB, employing strategies
such as positive stress management, planning and seeking
emotional support, whereas men use humour and illicit
drugs [104]. A Peruvian study suggested younger men have
a pronounced need for emotional support and caregiving
from their family – likely from mothers and sisters. The
study also highlighted partner support was significantly
more important for women [103]. Family support has been
shown to be important in the prevalence of depression
among TB patients [52, 117]. Women are more likely to
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attempt alcohol cessation and report negative consequences
of drinking on personal relationships, and less likely to jeop-
ardise their personal safety due to alcohol use [90].
Factors related to socioeconomic and education
background
Patients from lower education backgrounds are more
likely to suffer from depressive symptoms [38, 46, 52]
and psychological distress [40, 55], and more likely to
heavily consume alcohol [94]. Higher education levels
on the other hand has been linked to higher mental
health-related quality of life [109]. Patients from lower
socioeconomic backgrounds are less likely to adhere to
treatment [116], more likely to suffer depression [4, 38,
46, 117] and psychological distress [40, 55], and more
likely to be heavy alcohol users [94, 115]. HIV/TB coin-
fection is associated with depressive symptoms [49, 117],
while tobacco smoking has also been associated with
harmful alcohol use [55] and depression [4] among TB
patients. Retreatment, discontinuing treatment [49], and
history of TB [41] may make depressive symptoms more
likely, while patients who relapse treatment are more
likely to be heavy alcohol drinkers [94]. Finally, heavy al-
cohol use is related to higher levels of depression among
TB patients [41], similarly to diabetes [4].
The paucity of person-centred care
The paucity of person-centred perspectives in LMIC and
BRICS approaches to address comorbidities between drug-
sensitive and drug-resistant TB on the one hand, and men-
tal disorders on the other is clear from the scoping review
results. Focusing on person-centred care (as opposed to
patient-centred care) and following the required compo-
nents of patient narrative, collaboration and continuity [21],
our search yielded two studies, both in Nepal, that explicitly
aimed to develop more person-centred care to address the
psychosocial needs of MDR-TB [118, 119].
Some studies have aimed to develop patient-centred
models of care, for instance, a South African interven-
tion that trains social workers to support people suffer-
ing from drug-resistant TB [120]. In a study in
Nicaragua, TB clubs and home visits were implemented
to address TB patients’ internalised stigma, with some
success [121]. Medecins Sans Frontieres (MSF) devel-
oped and implemented a home-based MDR-TB treat-
ment programme in Northern Uganda, which was found
to be acceptable to patients, families, communities and
healthcare workers [122]. An Ethiopian study investi-
gated the extent to which the directly observed treat-
ment short course (DOTS) strategy is patient-centred,
showing that it falls short of achieving such care [123].
Baral and colleagues [118] aimed to explore challenges
people face receiving MDR-TB care in Nepal, and to co-
develop a person-centred intervention with patients and
families. The research underlined the financial and social
strains that conventional MDR-TB care places on indi-
viduals, including increased expenditure accessing care,
and challenges resulting from removal from social net-
works, stigmatisation, loneliness and medication side ef-
fects. An intervention combining psychosocial
counselling and added financial support was developed
with positive effects on treatment outcomes. Further re-
search from Nepal aimed to develop and test a psycho-
social support package to be integrated within routine
MDR-TB care [119]. Stakeholder voice was again priori-
tised, with patient, family member and service provider
perspectives elicited, providing understanding of the
physical and psychological impact of MDR-TB; the
intersection between health facilities, health information
and psychological dimensions of disease; patient contact
with family and social networks; personal living arrange-
ments; and financial circumstances and livelihood. De-
veloping the intervention collaboratively assisted in
strengthening stakeholder capabilities, opportunities and
motivations, resulting in more sustained psychological
support throughout treatment, especially for patients
with limited social support and who faced stigma [119].
While these developments are promising, little to no
empirical evidence exists on person-centred care models
for drug-sensitive TB programmes, or the impact or ef-
fectiveness of person-centred care in improving individ-
ual, clinical and programmatic outcomes.
Discussion
This review aimed to explore the nature and extent of
comorbidities between TB and mental illness symptoms
in LMICs, and to identify and describe person-centred
approaches to address such comorbidities. As expected,
studies that focused on intersections between TB and
mental illness symptoms in LMICs varied considerably
according to scope, size, study design and robustness,
making comparisons difficult. However, our findings
identified four broad tuberculosis and mental disorders
comorbidities namely alcohol use and tuberculosis, de-
pression and tuberculosis, anxiety and tuberculosis, and
general mental health and tuberculosis. Despite the wide
variance between research in different countries, it is
clear that experience of a TB disease episode is often ac-
companied by or related to CMD and alcohol use symp-
toms (see a summary of main findings in Table 3).
In contrast to research on HIV, there is limited empir-
ical data globally on the prevalence of mental illness
symptoms among people suffering from TB [59]. None-
theless, mental illness rates are higher among people with
physical illness compared to the general population, and it
might even be higher for people with TB – depression
and anxiety certainly seems to be higher [2]. Results from
the World Health Survey, conducted among 48 LMICs,
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suggest comorbid TB and depression significantly worsen
health outcomes across all domains, exceeding burdens of
TB and depression in isolation. Further, people suffering
from TB are almost at a fourfold increased risk of experi-
encing depressive episodes [4]. Our review demonstrated
that a body of evidence is growing in LMICs, rendering an
urgent need for standardised concepts and measurements
that incorporate person-centred systems of care.
Our findings suggest that initial diagnosis and treatment
phases of the TB episode are particularly salient in pre-
venting and treating mental health challenges, as baseline
mental illness symptoms negatively affect the treatment
phase [38]. Treating mental health challenges is a clinical
priority, with psychological distress potentially doubling
the risk of non-adherence [41]. Indeed, comorbid mental
illness – including substance use – is a major consider-
ation in treatment non-adherence which, in addition to
the impact on individuals, has wider public health implica-
tions, including significant contributions to transmission
and emergence of drug-resistant disease [2].
Research on TB and mental illness comorbidities that
stretch beyond describing cross-sectional prevalence rates
are rare, with very little attention paid to longitudinal di-
mensions of the trajectory of comorbidity [3]. Causal path-
ways between TB and depression are both complex and
multidirectional, manifesting in biological, pharmaceutical
and psychosocial mechanisms, though the extent to which
these pathways contribute to comorbidity burden remains
unclear [3, 38]. One mechanism suggests that depression
negatively affects self-care in TB treatment, thereby in-
creasing chances of treatment non-adherence and failure
[4]. Further, alcohol use before and during treatment has
a strong negative effect on a myriad of outcomes, mani-
fested in complex, bidirectional causal chains. Poverty can
lead to increased alcohol use, which in turn may lead to
an increased likelihood of contracting TB, not being
diagnosed in a timely manner, and not adhering to treat-
ment; also, alcohol use may lead to downward social mo-
bility, again creating social conditions favourable for TB
disease progression [99]. The review illustrated that there
are key nuances in TB and mental illness comorbidity;
women are more prone to depression, while men are
more likely to engage in harmful alcohol use. Men are also
less likely to adhere to treatment regimens. The gendered
dimension of comorbidity is an important consideration
in TB programme design and again underlines the need
for person-centredness. Other vulnerabilities such as pov-
erty, lower levels of education and older age groups
present further opportunities for more targeted
interventions.
Health system barriers – such as fragmented, non-
dependable health information systems, limited patient
management, referral and communication fractures be-
tween levels of care – further compound challenges dur-
ing the TB disease episode [124]. These are unfortunately
features of many national health systems in LMICs, creat-
ing a troubling context for reforms towards person-
centredness [125]. Importantly, many challenges faced by
TB patients lie outside the formal health system sphere –
transport problems, medication reactions and food assist-
ance [126]. A particular silence in current literature relates
to occupational dimensions of TB, both prevention and
treatment and care. The hidden epidemic of TB among
healthcare workers, and the resultant care approaches by
employers require urgent attention.
Despite recent growth in person-centred discourse in global
health (for instance in the SDGs, Lancet Global Health Com-
mission on High-Quality Health Systems in the SDG Era,
WHO Framework for People-centred Health Systems), our
review showed that little to no person-centric TB treatment
approaches are being deployed in LMICs, with the exception
of the two studies in Nepal, which focused on psychosocial
support for people suffering from MDR-TB [118, 119]. While
there is an increase in attention to patient-centredness in TB
care which include patients and their families in decision-
making, person-centredness considers the whole person in a
wider context rather than a focus on a person’s role as a pa-
tient. Very few studies have presented person-centred models
of care, as well as comparable empirical investigations into
cost effectiveness and programme effectiveness [127]. The
person-centred dimensions of patient narrative, collaboration
and continuity [21] still fall short in LMIC and BRICS re-
search. Stakeholder voice is especially critical; TB interven-
tions will only be able to achieve positive outcomes with the
full inclusion of patients, their families and wider network in
the planning and organisation of care [128].
Table 3: Main findings
This review suggested that there is increasing attention
being paid to the intersections of mental illness symptoms
Table 3 Key findings on the comorbidity of tuberculosis and
mental illness
• High co-morbidity of mental illness with TB (name the mental illnesses)
and very pronounced with MDR
• Where relationships between mental illness and TB have been shown,
we see consistent patterns to those for people without TB: women
tend to suffer more depression; men more alcohol; socioeconomic and
less education also more associated with more mental illness.
• Relationships bidirectional (most clearly for alcohol use disorders)
• Mental health needs are most pressing during the diagnostic and
treatment initiation phases of TB treatment
• Some evidence of resolution of mental illness symptoms with TB
treatment, but also concern that for MDR-TB symptoms persist for long
periods and even after treatment
• Patterns between TB and mental illness with poverty similar. Poverty
associated with higher incidence of both conditions and TB also
perpetuates poverty. The combination of poverty, TB and alcohol use
disorders appears particularly severe.
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and TB disease in LMICs. There are well-known vulner-
abilities during a TB episode – including those tied to the
patient, their family and broader context, as well as per-
sisting health system ills. At the very least, TB pro-
grammes should be targeted enough to be able to address
key challenges, especially dimensions of gender, education
and socioeconomic background. This review highlighted a
common feature of international research comparisons,
namely the lack of standardisation and fragmentation in
the use of different concepts. The study of mental illness
and TB crucially requires a globally accepted framework
that details the range and nature of comorbidities, as well
as robust methods of measurements. Similarly, there is an
identified need for a conceptual framework that sets out
the definitions of patient -and person-centred care as it
applies to TB. This will require wide consensus on the
meaning of these terms and how they are operationalised,
while inappropriate terms such as ‘TB suspect’ and ‘treat-
ment defaulter’ – with its subtle judgements and disem-
powerment – should be replaced by person-centred
terminology such as ‘people with presumptive TB’ and
‘person lost to follow-up’ [127].
Several concepts used during this review are not clear
cut, and its vagueness in interchangeable use renders
searching and comparison difficult. Mental illness symp-
toms are notoriously difficult to pin down, and many nu-
ances go astray during its operationalisation in research.
For example, the degree to which alcohol use become a fea-
ture of mental illness is not always made entirely clear by
researchers, and the distinction between the initial shocks
of a TB diagnosis should be differentiated from formally di-
agnosed anxiety. Similarly, it is possible that some papers
might have been missed during the search due to treatment
approaches and care not explicitly being named “person-
centred”, “patient-centred” or “people-centred”, rather im-
plicitly inferring dimensions of these terms (for instance,
“including the patient in decision-making”.
Conclusions
The literature clearly showed that the presentation of
mental illness – including substance use, anxiety and de-
pression – during the TB disease trajectory, have a range
of negative outcomes. This is often exacerbated in LMICs
where the majority of people suffering from TB are often
faced with complex challenges such as poverty, gender
disparities, limited education and failing health systems.
Moreover, mental illness and TB comorbidities were
found to be more prevalent within the diagnostic phase
and later the treatment stages. These phases were found
to be associated with high levels of psychological distress
thus often requiring more person-centred TB care models.
Addressing psychosocial comorbidities with TB in LMICs
and BRICS with person-centred TB care in routine care
platforms may yield promising clinical and psychosocial
outcomes.
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